Site Selection in Europe: Germany, UK, Netherlands Rank High
Against the backdrop of recent statistics showing that applications to run clinical trials in Europe fell 25% between 2007-2011
Against the backdrop of recent statistics showing that applications to run clinical trials in Europe fell 25% between 2007-2011, the SAT-EU study group, an independent non-profit collaborative initiative, supported by the European Forum for Good Clinical Practice (EFGCP) and several other trade and not-for profit organizations, announced the results of a survey, Factors Influencing Clinical Trial Site Selection in Europe: The Survey of Attitudes towards Trial Sites in Europe. Published research based on that survey is now online in the British Medical Journal's BMJ Open.
Apparently, administrative burdens and unhelpful bureaucratic barriers are key deterrents to running clinical trials in Europe, according to the survey, while costs of running trials, as week as any governmental or financial incentives are considered to be of lower importance. “This study seems to indicate that fostering competitiveness of European clinical research may not require additional government spending/incentives. Rather, harmonization of approval processes, greater visibility of centers of excellence, and reduction of hidden indirect costs, may bring significantly more clinical trials to Europe,” commented Ingrid Klingmann, Chairman of the European Forum for Good Clinical Practice (EFGCP).
The research paper also found considerable variability in the perceived receptivity of countries to undertake clinical trials. Germany, the United Kingdom, and the Netherlands were consistently rated the best trial markets, which led authors to suggest a best practice audit of provisions governing clinical trials in these countries would be helpful.
Applied Clinical Trials supported the survey by providing outreach for the collaborative study group survey to our readership.
You can read the full release here.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Empower Sponsor Success with Insights from Sites
October 3rd 2024Are you tired of clinical trial technology that slows down processes? Are your sites looking for more intuitive solutions? At YPrime, we’ve taken a deep dive into site experiences and perspectives, sharing ways to bridge the gap between sponsors, sites, and patients, to foster a more efficient clinical trial process.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
New Survey Uncovers Distrust as Key Factor in Enrollment Declines Among Black Patients
October 2nd 2024Findings from two Baltimore medical centers presented at the American Society for Radiation Oncology Annual Meeting suggest spiritual themes and distrust may be behind the decline in trial participation.
Tulisokibart Shows Superior Efficacy in Achieving Clinical Remission for Ulcerative Colitis Patients
October 2nd 2024Proof-of-concept Phase II ARTEMIS-UC trial shows efficacy of investigational humanized monoclonal antibody tulisokibart in treating inflammatory bowel disease compared with placebo.
